Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer. - Wikidata - wikimedia - TriplyDB

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

http://www.wikidata.org/entity/Q30239825

about

How and when adjuvant treatment should be intensified in stage III colorectal cancers?Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.

P2860

Q38638844-7C805FA2-2E0C-4B74-8533-CE4F543936AC Q51825453-A11F8F92-E8D9-48D6-8EC2-6259A0B7F094

P2860

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

http://www.wikidata.org/entity/Q30239825

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@ast

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@en

type

label

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@ast

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@en

prefLabel

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@ast

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@en

P1433

Q30239825-CD5ED880-F34D-46A1-B0DE-8CC4ACB616D9

P1476

Q30239825-3D12658B-83F3-413D-AE53-C468B6BF7033

P2093

Q30239825-0B40CE65-5A66-4BEF-AF5F-4AFC05C07052

Q30239825-15B06A8D-69DD-4A3E-ABBD-50CD562FE12A

Q30239825-511244A4-6312-4695-869C-E641C0A9BF80

Q30239825-9C71160F-7695-4038-9287-5F7CCB9E5A0F

Q30239825-A3D42908-3F1F-4D26-953F-1E2CE1AE35C4

Q30239825-D0A5210D-C360-4DF3-98E3-BAB4D95F5302

P2860

Q30239825-02500684-DB59-4EEC-8FCC-410B3A3231F2

Q30239825-0256CD42-73C0-425F-9E4E-F18CF365F9FA

Q30239825-06C7833D-5EF3-47BA-BF16-AB5965B2BA47

Q30239825-0AA6C3A0-EFAD-4D02-A21F-5CACFF58C6E9

Q30239825-0E23D449-F960-4E0F-A9FD-02F551274AAB

Q30239825-12BB3A65-19D4-4B06-A4FC-1883105B1451

Q30239825-14EF8A2D-304D-4635-BC0A-C33C6A4EDB30

Q30239825-18C6C9E0-F07A-42F6-BEBC-5F72F60C449E

Q30239825-1FE43F24-5F62-487E-93F5-42F10E0415A4

Q30239825-228CCE10-9BD1-4352-932D-0944909B438F

P304

Q30239825-0F28F18C-5843-4337-91A0-A3ADB6DC7E55

P31

Q30239825-FDCCA345-AFF0-4E60-9C6C-453D3CC7C637

P356

Q30239825-960FBA93-ADDF-41B0-877D-CAF2B49C099D

P407

Q30239825-C1501DD2-0E55-45DB-AC7A-AFECA5D51E50

P433

Q30239825-628EBE5D-3D63-4807-B191-2E19C49EB3DB

P478

Q30239825-1B467CC0-B93F-483F-B2FB-FB9483617000

P50

Q30239825-577B3BC1-2263-433D-9E4A-655E6428E516

P577

Q30239825-69D0DC69-DD24-49A0-BBA5-FD4AFAB7284D

P698

Q30239825-4F4DF705-0D30-40C1-8C89-404DAD2D3C8F

P921

Q30239825-11A4ED78-48AC-427F-8913-FE24AACCE8DB

P356

P1433

Future Oncology

P1476

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

@en

P2093

Cecilia Cerebelli

http://www.w3.org/2001/XMLSchema#string

Charles Honoré

http://www.w3.org/2001/XMLSchema#string

Dominique Elias

http://www.w3.org/2001/XMLSchema#string

Janina Fl Huguenin

http://www.w3.org/2001/XMLSchema#string

Léonor Benhaim

http://www.w3.org/2001/XMLSchema#string

Maximiliano Gelli

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options

Global cancer statistics, 2002

CD44 is the principal cell surface receptor for hyaluronate

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma.

Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

P304

907-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0389

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28052691

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer